1. Nicholson S, Sainsbury JRC, Halcrow P, Kelly P, Angus B, Wright C, Henry J, Farndon JR, Harris, AL: Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br J Cancer 63:146?150, 1991
2. Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ, Harris AL: Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet i:1398?1402, 1987
3. Klijn JG, Berns PM, Schmitz PI, Foekens JA: Epidermal growth factor receptor (EGF-R) in clinical breast cancer: Update 1993. Endocr Rev Monographs 1:171?174, 1993
4. Klijn JG, Berns PM, Schmitz PI, Foekens JA: The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr Rev 13:3?17, 1992
5. Bolla M, Chedin M, Colonna M, Marron J, Rostaing PB, Chambaz E: Prognostic value of epidermal growth factor receptor in a series of 303 breast cancers. Eur J Cancer 28A:1052?1054, 1992